Phillip G. Febbo - Feb 21, 2023 Form 4 Insider Report for ILLUMINA, INC. (ILMN)

Role
SVP Chief Medical Officer
Signature
/s/ Robert Maynes for Phillip Febbo
Stock symbol
ILMN
Transactions as of
Feb 21, 2023
Transactions value $
-$252,536
Form type
4
Date filed
2/23/2023, 04:34 PM
Previous filing
Nov 8, 2022
Next filing
Mar 3, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ILMN Common Stock Options Exercise $0 +3.52K +71.11% $0.00 8.48K Feb 21, 2023 Direct F1
transaction ILMN Common Stock Tax liability -$253K -1.25K -14.69% $202.84 7.23K Feb 21, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ILMN Performance Shares Options Exercise $0 -3.52K -100% $0.00* 0 Feb 21, 2023 Common Stock 3.52K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020.